Dr. Samer Souheil Nasser, MD

Dr. Nasser practices at U.S. Renal Care Weymouth Dialysis in Brockton, Massachusetts.

Dr. Nasser's NPI, 1922276294, was assigned on February 20, 2008. Dr. Nasser holds Massachusetts license 2644957.

Dr. Nasser's primary practice is U.S. Renal Care Weymouth Dialysis, at 830 Oak St, Brockton, MA 02301 in Plymouth County. The practice phone is (781) 340-3938.

Dr. Nasser's primary practice is U.S. Renal Care Weymouth Dialysis in Brockton, Massachusetts. Dr. Nasser is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Nasser to 4 more hospitals, 5 dialysis centers, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nasser practices, 12 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Nasser's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Nasser is licensed in Massachusetts.

CMS data shows 9,941 Medicare services from Dr. Nasser across 41 procedure codes in 2024, for 773 Medicare patients. Medicare paid $275,305 for them.

CMS counts 773 Medicare patients who saw Dr. Nasser in 2024. The largest group is 75 to 84, with 323 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nasser's median patient age at 74, with 51% women.

In 2024, Dr. Nasser wrote 2,312 Medicare Part D claims for 475 patients. 84% of them were for generic drugs. CMS names the drug for 2,067 of them, across 40 drugs with 11 or more claims each, at $667,624 in total drug cost. In 2023, CMS named 1,978 claims across 44 drugs.

Dr. Nasser accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nasser as offering telehealth.

Dmand AI links 7 papers to Dr. Nasser, published from 2012 to 2016. 2016 was the busiest year, with 2. Dr. Nasser's most frequent co-authors are Mariya H. Apostolova, MD, Zein A. Farhat, MD and George J. Frem, MD.

CMS Open Payments shows 7 general payments to Dr. Nasser from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. NxStage Medical, Inc. paid the most, $101.